Aclarubicin
WikiDoc Resources for Aclarubicin |
Articles |
---|
Most recent articles on Aclarubicin Most cited articles on Aclarubicin |
Media |
Powerpoint slides on Aclarubicin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Aclarubicin at Clinical Trials.gov Clinical Trials on Aclarubicin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Aclarubicin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Aclarubicin Discussion groups on Aclarubicin Patient Handouts on Aclarubicin Directions to Hospitals Treating Aclarubicin Risk calculators and risk factors for Aclarubicin
|
Healthcare Provider Resources |
Causes & Risk Factors for Aclarubicin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Aclacinomycin A
Overview
Aclarubicin is an anthracycline drug [1] that is used in the treatment of cancer. Soil bacteria Streptomyces galilaeus can produce aclarubicin.
References
- ↑ Jensen PB, Jensen PS, Demant EJ, Friche E, Sørensen BS, Sehested M; et al. (1991). "Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II". Cancer Res. 51 (19): 5093–9. PMID 1655244.